28 Though an increasing trend in the use of GLP1-ras and SGLT2is was evident, reflecting the transition toward therapies that offer advantages that go beyond the metabolic control of glucose, such as reducing the risk of cardiovascular events and the progression of renal function deterioration in patients suffering from T2DM, t
← all excerpts
Noninsulin antidiabetic prescription patterns in Colombia: a cross-sectional study.
1
—
—